| Identification | Back Directory | [Name]
Sulfamic acid, N-[2-[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-[[(2S)-2,6-diamino-1-oxohexyl]amino]-2,6-bis(1-methylethyl)phenyl ester, hydrochloride (1:2) | [CAS]
199983-77-2 | [Synonyms]
ACAT-IN-10 dihydrochloride
Sulfamic acid, N-[2-[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-[[(2S)-2,6-diamino-1-oxohexyl]amino]-2,6-bis(1-methylethyl)phenyl ester, hydrochloride (1:2) | [Molecular Formula]
C35H57ClN4O5S | [MOL File]
199983-77-2.mol | [Molecular Weight]
681.37 |
| Hazard Information | Back Directory | [Uses]
ACAT-IN-10 dihydrochloride is an acyl-Coenzyme A:cholesterol acyltransferase (ACAT) inhibitor extracted from patent EP1236468A1, example 197. ACAT-IN-10 dihydrochloride weakly inhibits NF-κB mediated transcription[1]. | [References]
[1] Joseph Anthony Cornicelli, et al. Sulfonylaminocarbonyl derivatives for the treatment of nuclear factor-kappa B mediated diseases and disorders. EP1236468A1. |
|
|